Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

The expanded facility will focus on manufacturing injectable medicines, device assembly and packaging for medicines across ...

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of ...

The acquisition is expected to be completed in the coming days.

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

In anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, BioVaxys ...

Prasinezumab continues to be well tolerated and no new safety signals were observed.

A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...

PTC Therapeutics Inc. has submitted the vatiquinone New Drug Application (NDA) for the treatment of children and adults ...

With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and ...

Integration of Ori's IRO Platform with Cue and Lovo processing systems aims to enhance efficiency in CGT manufacturing.

AbbVie has agreed to acquire Nimble Therapeutics, including its lead asset, an investigational oral peptide IL23R inhibitor ...